Eligibility criteria
Condition
Advanced Non-Hematologic Malignancies
Sex
Females and Males
Age
18 + years
Inclusion criteria
Show details
- Age greater than 18 years
- Documented advanced-stage non-hematologic malignancy for whom docetaxel monotherapy is
a reasonable treatment option
- Eastern Cooperative Oncology Group [ECOG] performance status 0-1
Exclusion criteria
Show details
- Significant active cardiac disease
- Chemotherapy, biological or investigational agents within 4 weeks prior to dosing
- Inadequate bone marrow, renal, cardiac or liver function